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Summary
Malnutrition has been defined as a “state resulting from
lack of uptake or intake of nutrition, leading to altered
body composition and body cell mass, as well as to di-
minished physical and mental function and impaired clini-
cal outcome from disease.” Particularly for the multimorbid
medical inpatient, there are multiple research studies link-
ing malnutrition to adverse clinical outcomes independent
of type of acute and chronic illnesses. Importantly, recent
trials have shown that malnutrition is indeed a modifiable
risk factor with specific individualised nutritional support in-
terventions started at hospital admission having positive
effects on the risk of complications, mortality, functional
outcomes, rehospitalisation and quality of life. Under-
standing the optimal use of nutritional support in patients
with acute illness is complex – as timing, route of delivery,
and the amount and type of nutrients can all affect patient
outcome. The aim of this narrative review is to provide a
practical guideline for pragmatic and evidence-based as-
sessment and treatment of medical inpatients at nutritional
risk. We thereby focus on screening, patient assessment,
definition of individual nutritional goals and nutritional sup-
port interventions that help patients to reach these goals.
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Introduction
Hippocrates, one of the founders of medicine as a scien-
tifically orientated profession, had already considered nu-
trition as a major factor to help cure diseases. The sig-
nificance of nutrition in clinical practice, however, has
never quite fulfilled those expectations [1, 2]. Many physi-
cians still do not consider nutrition as a medical treatment
but rather as a supportive treatment [3]. As recent trials
demonstrated that early, individualised nutritional support
improves clinical outcomes of patients, it is now time for
a paradigm shift [4–7]. We must now think of clinical nu-
trition as a medical treatment that, by decreasing metabol-
ic stress responses, preventing apoptosis, reducing oxida-
tive stress in other organs and modulation of the body’s
immune response, has a measurable impact on disease de-
velopment and recovery [8, 9]. This is particularly true for
patients with malnutrition, a condition that has been as-
sociated with increased risks of adverse clinical outcomes
[10]. In such patients, a nutritional strategy needs to be es-
tablished in order to provide optimal nutritional support.
There are three basic prerequisites:
1. Routine screening with a well-tested and validated tool
for early identification of patients with manifest mal-
nutrition or those at high risk of developing malnutri-
tion;
2. Shared interdisciplinary and multiprofessional respon-
sibilities for a thorough clinical assessment and the im-
plementation of an up-to-date nutritional therapy based
on current evidence where appropriate;
3. Clinical decision making regarding optimal nutritional
care for an individual patient guided by a systematic
consensus algorithm.
This review article provides an example of a nutritional
support strategy and discusses basic principles of nutri-
tional therapy for medical inpatients. The nutritional sup-
port interventions discussed are mainly based on consensus
guidelines issued by the European Society of Clinical Nu-
trition and Metabolism (ESPEN) [11]. As the underlying
evidence, however, is variable in quality and reliability,
some of the recommendations are supported only by expert
opinions and may need to be adapted once new evidence
becomes available.
Implementation of a nutritional care strategy:
cornerstones
Establish a nutritional care team
Interdisciplinary as well as multiprofessional support and
shared decision making is needed for optimal nutritional
care [12]. Appropriate duties and responsibilities must be
assigned in order to ensure that each involved profession
can provide important contributions. Interdisciplinary
communication should be integrated into daily routine on
the ward. Responsibilities may be shared as follows:
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– Nursing team
– Involvement in nutritional screening of patients. Docu-
mentation of oral intake and weight changes; physical
and motivational support during meals.
– Dieticians
– Detailed nutritional assessment. Meal planning accord-
ing to predefined goals and special needs, with special
adjustments according to the underlying disease and
current clinical circumstances. Building connection to
hospital kitchen for food enrichment.
– Physicians
– Nutritional assessment and exclusion of drugs leading
to weight loss. Adaptation of nutritional interventions
according to on-going medical treatment particularly
considering potential interaction with other medica-
tions. Responsibility for clinical and laboratory moni-
toring as part of the daily routine, also regarding the
management of the refeeding syndrome.
– Hospital kitchen
– Preparation of specific and fortified foods to facilitate
oral nutritional therapy.
Implement routine nutritional risk assessment
Screening for malnutrition should be performed at the time
of patient admission to the medical ward or at least within
the first 24–48 hours. The use of a validated screening
tool for nutritional risk is recommended; for example, the
Nutritional Risk Screening 2002 (NRS 2002) or the Mini
Nutritional Assessment short form (NMA-sf) [11, 13, 14].
Several recent studies have used the NRS 2002 and pro-
vided evidence that this score has strong prognostic impli-
cations and identifies patients who benefit from nutrition-
al support interventions [6, 9, 15, 16]. The NRS 2002 (see
fig. 1) includes an assessment of the patient’s nutritional
status (based on weight loss, body mass index [BMI] and
general condition or food intake) as well as disease sever-
ity (stress metabolism), and indicates any increased risk of
adverse outcomes [13]. Each risk predictor is scored from
0 to 3 points and patients receive 1 extra point if they are
aged 70 years or older [13].
If the screening test is positive, a more detailed assessment
of nutritional status is recommended. Table 1 gives an
overview of anthropometric and laboratory parameters
useful for baseline examination of a patient at risk. In some
cases of severe or chronic malnutrition, there may be a
need for additional diagnostic studies (e.g., if pancytopenia
is present). These patients may benefit from the involve-
ment of an experienced specialist in malnutrition.
Create a nutritional care plan for the medical ward
If malnutrition is manifest or presents an imminent risk,
an individualised nutritional support strategy should be es-
tablished within 48 hours after hospital admission. In a
first step, a trained dietician should calculate individual
goals for daily energy and protein requirements for each
patient. Details on establishing individual nutritional ob-
jectives will be discussed in the following text. We recom-
mend introducing a nutritional care plan flow chart system
to guide further management, achieve individual nutrition-
al goals and assure decision-making consistency within the
Figure 1: NRS 2002, adapted from Kondrup et al. [13] with permission from Elsevier.BMI = body mass index; COPD = chronic obstructive pul-
monary disease; APACHE-II = APACHE-II Score
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hospital. Figure 2 presents a pragmatic algorithm for nutri-
tional management of patients (adapted from the EFFORT
trial [15]).
Define nutritional targets
Estimate energy needs
Terms and abbreviations:
Resting energy expenditure (REE) or resting metabolic
rate = energy required for the preservation of metabolic
functions in a biologic equilibrium under resting condi-
tions, and fasting.
Total energy expenditure (TEE) = REE + dietary-induced
thermogenesis + physical activity
The formula of TEE is based on the energy balance of
healthy probands. Diseases affect energy requirements by
their impact on metabolic processes, in particular by in-
creasing catabolism. Therefore for patients, the general
formula has to be further adjusted by adding a disease-spe-
cific factor. Disease-specific factors range between 5 and
50% of the REE.
There is not one single validated method to estimate energy
requirements [11]. The gold standard to estimate energy
needs is indirect calorimetry, which is, however, time con-
suming, resource intensive and technically complex [18].
REE also varies according to the severity of the illness
(hypermetabolism). Repeated measurements would have
to be taken in order to ensure continuity. As a result of
these factors, energy needs are in clinical routine often es-
timated using equations based on the calculation of resting
metabolic rates. There is a multitude of evaluated predic-
tion equations using sex, weight, height and age (e.g., Har-
ris-Benedict-Formula 1919, FAO/WHO/UNU 1985, Mif-
flin-St Jeor 1990) or simple weight-based formulae (e.g.,
25–30 kcal / kg bodyweight / day; BASA-ROT-Table) [11,
19, 20]. Most of these equations provide good estimates for
groups of patients but show significant imprecision in in-
dividual cases; which can lead to both over- and underes-
timation of energy expenditure [19]. It is therefore recom-
mended to use a tool that is easier to implement but still
reliable in clinical practice. Estimates of energy expendi-
ture are helpful to define a starting point but need adap-
tation during the course of the hospitalisation. In the case
of uncertainty, additional indirect calorimetry may be per-
formed [11].
Recommendations for weight-based formulae according to
ESPEN guidelines are [11]:
– REE for patients aged ≥65 years or polymorbid pa-
tients: 18–20 kcal / kg bodyweight / day
– TEE for patients aged ≥65 years or polymorbid pa-
tients: 27 kcal / kg actual bodyweight / day
– REE for severely underweight patients (i.e., <50kg): 30
kcal / kg bodyweight / day
Protein requirements
Overall, there are few studies assessing the effect of differ-
ent amounts of protein intake on outcome. Some clinical
data suggest that a protein intake of >1 g / kg bodyweight /
day appears to reduce the risk of complications and weight
loss [21]. In terms of clinical and functional outcome, older
and polymorbid patients may benefit from a higher protein
intake, for example 1.5–2 g / kg bodyweight / day [17, 22].
Also, a daily protein intake of 1.2–1.5 g / kg bodyweight
to adjust for targets for patients suffering from acute renal
failure (0·8 g / kg bodyweight / day) [11, 17, 24].
There are several uncertainties regarding the optimal use
of proteins in clinical nutrition. First, there is uncertainty
whether calculations of protein requirements should use
actual or ideal body weight as their reference [25]. This is
relevant particularly in obese patients, where protein goals
calculated from the actual body weight result in very high
quantities and often are difficult to reach. Based on patho-
physiological considerations, calculating protein needs ac-
cording to ideal body weight should provide adequate
quantities and should be preferred in clinical practice [26].
However, so far, there is no evidence supporting this as-
sumption. Second, in addition to protein quantity, it re-
mains largely unknown which type of protein has most
beneficial effects on patient outcomes.
Micronutrients
Malnourished patients are at risk for micronutrient defi-
ciency as a result of decreased intake or increased require-
ments [11]. Thus, screening for micronutrient deficiencies
such as iron, vitamin B12, folic acid and vitamin D are rec-
ommended. According to patient history and clinical pre-
sentation, in particular in cases of severe or chronic malnu-
trition, more comprehensive screening including vitamin
B1, vitamin B6, vitamin A, vitamin E, vitamin C, zinc
and selenium, as well as the international normalised ratio
(INR) or Quick test as an indirect measure of vitamin K
should be considered. Analytic prerequisites for all labora-
tory parameters, in particular for vitamin E, should be fol-
lowed carefully in order to ensure reliable results.
Cases of general vitamin depletion are also at increased
risk for serious trace element deficiency. In absence of
specific toxicity risks or known micronutrient adequacy,
supplements should cover both, ideally in a multivitamin/
multi-trace-element formula [11]. The recommended daily
Table 1: Basic assessment at admission.
Parameter Significance and implications
NRS 2002 Screening for malnutrition
Iron, holotranscobalamin, folic acid in erythrocytes Diagnostic assessment of anaemia. Substitution in the case of deficiency
Electrolytes (sodium, potassium, calcium, magnesium, phos-
phate)
Screening for deficiency and assessing risk for refeeding syndrome. Substitution according to the cited con-
sensus paper by Friedli et al., Nutrition, 2018 [28].
Creatinine Baseline assessment of renal function. Possible sign for low muscle mass if low
Liver function tests Baseline assessment of hepatic status
International normalised ratio Indication of vitamin K deficiency, if low. Substitution if clinically indicated.
Caveat elevated/reduced by coumarins and direct-acting oral anticoagulants.
Vitamin D Baseline assessment because of frequent deficiency and frequent association of osteoporosis in malnutri-
tion. Substitution in the case of deficiency
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Figure 2: Algorithm flow chart for nutritional support in medical inpatients, adapted from Bounoure et al. [17] with permission from Elsevi-
er.REE = resting energy expenditure; AF = activity factor; DF = disease factor; RDA = recommended daily allowance; GFR = glomerular filtra-
tion rate
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intake may temporarily be exceeded in order to replace de-
pleted stores [11]. General prescription of a multivitamin/
multi-trace-element supplement does not seem to be cost-
effective but, depending on circumstances, it might be rea-
sonable to prescribe one to prevent recurrent multivitamin/
multi-trace-element deficiency after repletion and/or in the
presence of persisting risk factors for malnutrition [27].
Particularly in patients at risk for refeeding syndrome,
careful monitoring and substitution of vitamins and mi-
cronutrients is important [28, 29].
Disease-specific supplementation
Immuno-nutrition (e.g., antioxidants, omega-3-fatty acids,
branched-chain amino acids), prebiotics and probiotics
Multiple new formulas with potential immune-modulating
capacities are currently gaining attention for use in specific
patient populations, particularly in intensive care units and
surgical wards. To-date there is no strong evidence for
their beneficial influence on clinical outcome in medical or
polymorbid non-critically ill patients [11].
Amino acids for wound healing in pressure ulcers
According to a randomised controlled trial by Wong et al.,
wound healing might be improved by adding a combina-
tion of amino acids (β-hydroxy-β-methylbutyrate [βHMB],
glutamine and arginine) to a hypermetabolic diet (energy
goals 30–35 kcal / kg bodyweight / day) in patients with
pressure ulcers [30].
Fibre
Fibre supplementation has been recommended to improve
bowel function and feeding tolerance and reduce diarrhoea
with enteral nutrition [31]. Although the pathogenesis of
diarrhoea in patients receiving enteral nutrition in most
cases is multifactorial, the fibre content of enteral formulas
might be one of the relevant factors. Fibre content also in-
fluences clinical parameters such as gastrointestinal tran-
sit time, bowel frequency and daily stool wet weights [32,
33]. In an attempt to prevent diarrhoea, the fibre content of
enteral formulas has been adapted to better reflect the fi-
bre content of normal food. Results have so far been incon-
clusive, with heterogeneity among study protocols in terms
of fibre type, blended versus single fibre source and dose
of fibre content. This heterogeneity may be explained by
the dependence of gastrointestinal effects on fibres solubil-
ity in water and fermentability by the microbiota. Still, ac-
cording to a recent meta-analysis formulas containing fibre
may reduce risk of diarrhoea as compared with fibre-free
formulas particularly in non-critically ill medical patients
[32]. One randomised controlled trial included in the meta-
analysis, which focused on elderly non-critically ill pa-
tients with relevant protein malnutrition, came to a conclu-
sion similar to the overall conclusion by Elia et al. [31, 32].
Additionally, formulas containing a blend of soluble and
insoluble fibres resulted in better gastrointestinal tolerance
and reduced diarrhoea in comparison with single source fi-
bre [33]. Further, formulas predominantly containing par-
tially hydrolysed guar gum as their source of soluble fibre
seem to be better than other fibre types in the prevention
of diarrhoea. Hence, it is recommended to use an enteral
nutrition formula enriched with a mix of soluble and insol-
uble fibres, particularly in patients receiving enteral nutri-
tion and experiencing diarrhoea.
Maintenance fluid supplementation
In general, electrolyte-free fluid requirements of adults
range from about 1500–2000 ml or 25–30 ml / kg body-
weight / day for routine maintenance of fluid balance [36,
37]. Particularly in older patients, fluid needs should be
closely monitored in order to ensure that minimum goals
are met regularly [37]. During the course of the hospitali-
sation fluid supplementation should be re-evaluated daily.
An appropriate re-evaluation takes several parameters in-
to account: electrolytes, particularly sodium, clinical fluid
balance, oral intake, fluid supply by enteral or parenteral
nutrition, fluid losses and clinical circumstances such as
inflammation.
Parameters of nutritional support
Indication and timing
Systematic screening of at-risk patients at the time of hos-
pital admission for malnutrition using the NRS 2002 en-
ables the nutritional care team to plan a thorough and rapid
assessment of nutritional status, and concomitantly allows
the establishment of nutritional support within the first 48
hours. It is important to note that outside critical care, there
are few clinical studies comparing the effects of early with
late start of nutritional intervention on clinical outcome. A
randomised controlled trial by Heregova found less loss of
lean body mass, as well as improved recovery to baseline
lean body mass, in patients treated with early nutritional
support and low intensity exercise [38]. In addition, the in-
tervention group retained more independence for perform-
ing activities of daily living [38]. In intensive care settings,
studies have suggested that early start of (over-)nutrition,
particularly when parenteral nutrition is used, may have
harmful effects [11]. Still, evidence from intensive care
settings should not unconditionally be adopted on medical
wards because of differences in underlying disease, extent
of inflammation and resulting catabolism. Thus, for the
medical inpatient, early start of nutritional support is rec-
ommended.
Route of administration
For a patient who tolerates oral nutrition, the paradigm “If
the gut works, use it!” should be followed for both the in-
tensive care setting and the medical ward. Several high-
quality, randomised controlled trials in critical care settings
favour enteral over parenteral nutrition owing to reduced
risk of infectious and noninfectious complications [11].
For medical ward patients, a step-wise escalation of nutri-
tional support should be made as follows.
Oral nutritional support through fortification of the stan-
dard hospital diet or oral nutritional supplements
The positive effect of oral nutritional supplements (ONSs)
has been documented in several high-quality randomised
controlled trials with medical inpatients. The effects in-
cluded preservation of lean body mass and retained inde-
pendence for activities of daily life, as well as reduced
complications during hospitalisation and nonelective read-
missions [21, 38–40]. ONSs did not negatively affect oral
food intake and therefore did not disguise or inhibit in-
creasing appetite of patients, particularly if given in be-
tween meals or in the evening [38].
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Enteral nutrition via nasogastric tube in the event of in-
sufficient oral intake
Insufficient oral intake has been defined by the ESPEN as
an oral intake ≤75% of the estimated daily energy needs
[11]. The most frequent limiting factors for enteral nutri-
tion in clinical practice are intolerance of the nasogastric
tube, nausea and diarrhoea. Diarrhoea in particular may
present a relevant problem. To improve gastrointestinal
tolerance of enteral nutrition, we propose the following:
– Start with small portions and adjust slowly to target
quantities;
– Use formulas containing soluble and non-soluble fibres;
– Consider switching to a formula containing oligopep-
tides instead of proteins in the event of persistent diar-
rhoea
Parenteral nutrition via central or peripheral venous
catheter
Parenteral nutrition is mainly indicated in patients not tol-
erating oral and enteral nutrition as a result of intestinal
dysfunction and oral or enteral intake ≤75% of the estimat-
ed daily energy needs.
Discontinuation
Discontinuation or de-escalation of nutritional support is
recommended if gastrointestinal tolerance, appetite and
oral intake improve. No significant suppression of appetite
was seen in one high-quality randomised controlled trial on
ONSs, but data on enteral and parenteral nutrition remain
controversial [41].
We expect a partial reduction of appetite. In our own expe-
rience, the appetite-suppressing effect is lower in patients
experiencing fast recovery or those ready to transition to
the early rehabilitation phase.
Nutritional therapy should be withdrawn if ≥75% of rec-
ommended energy needs are met orally [11].
Monitoring/reassessment
A regular evaluation of effects of nutritional therapy as
well as screening for undesirable side effects are recom-
mended during a nutritional therapy regimen.
In order to evaluate the improvement of a patient’s nutri-
tional status, we recommend reassessing the anthropomet-
ric and laboratory parameters as shown in table 2. Oral
intake and gastrointestinal tolerance in case of enteral nu-
trition should be evaluated every 24–48 hours. An esca-
lation from oral to enteral and parenteral nutrition is rec-
ommended if there is no favourable development within 5
consecutive days. The adequacy and achievements of nu-
tritional goals should be re-evaluated every 24–48 hours,
always under consideration of the severity of the acute ill-
ness.
Screening for negative side effects of nutritional therapy
includes screening for refeeding syndrome, as well as for
hyperglycaemia and hypertriglyceridaemia in patients re-
ceiving parenteral nutrition (metabolic monitoring).
Historically, albumin has been considered as one of the
main nutritional laboratory parameters [42]. Yet its relia-
bility is as a marker of malnutrition is limited. The inter-
pretation of albumin levels is, among other reasons, mainly
complicated by its long half-life of about 21 days and its
property as a negative acute phase protein [43]. Pre-albu-
min, with a half-life of about 3 days, is a better marker of
recent food intake, yet is often not available in routine lab-
oratory testing and its interpretation remains challenging
if a patient presents with inflammation. It is therefore not
generally recommended to consider albumin as a nutrition-
al parameter, nor is it recommended in the basic work-up
of malnutrition. Exceptionally, it might complement an ex-
tensive malnutrition work-up in the hands of experienced
clinicians.
Risk of refeeding syndrome
Refeeding syndrome (RFS) is a condition resulting from an
anabolic reaction caused by nutritional therapy and is as-
sociated with serum electrolyte shifts (mainly potassium,
magnesium and phosphate), thiamine deficiency and clin-
ical symptoms (e.g., oedema, tachypnoea, tachycardia) re-
sulting from metabolic changes and an imbalance of fluids.
The main trigger for RFS is a switch from a catabolic to
an anabolic state, as a normal physiological reaction dur-
ing the beginning of the replenishment phase [29]. In most
cases, RFS appears within the first 3 days of initiating nu-
Table 2: Monitoring during nutritional therapy.
Parameter Significance and implications Frequency
Weight Evaluation of nutritional support. Caveat confounded by fluid retention Daily
Oral food consumption Evaluation of nutritional support 3 × daily
Laboratory parameters Sodium, potassium, magnesium,
phosphate
Screening and follow-up of RFS Daily
Follow-up if supplemented Daily
Follow-up in gastrointestinal loss Daily
Steady state after resolution of deficiency or RFS Twice weekly
Ionised calcium At the beginning of supplementation Daily
Under established supplementation Weekly
Glucose Treatment control in diabetics 3–6 × daily
Screening under EN and PN Daily at start and after dose ad-
justment
Creatinine Follow-up of renal function Weekly
Liver function tests Follow-up of hepatic function in acute illness Weekly
Screening for liver failure under PN Twice weekly
International normalised ratio Follow-up if supplemented Daily
Follow-up in steady state Weekly
Triglycerides Screening for hypertriglyceridaemia under PN Twice weekly
EN = enteral nutrition; PN = parenteral nutrition; RFS = refeeding syndrome
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tritional support [44]. It commonly occurs with all types
of nutritional support, but the risk is higher in patients re-
ceiving enteral or parenteral nutrition [45]. Clinically, RFS
may present as a mild form with almost no clinical signs
and no risk to the patient, or as more severe forms causing
clinical deterioration, including sudden cardiac death [46].
In patients with a high risk of developing RFS, daily mon-
itoring of electrolytes is recommended, at least during the
first 2–4 days following initiation of nutritional support or
relevant dose adjustments of enteral and parenteral nutri-
tion. Additionally, physical examination focusing on bal-
ance of fluids and a daily electrocardiogram in high-risk
situations should be performed. RFS can be prevented by
low levels of energy administration during the first phase
of feeding and a slow progression of dose adjustments.
Recently, a clinical practice guideline (consensus paper)
has been published discussing risk assessment, prevention,
treatment and monitoring of patients with RFS in more de-
tail [28].
Summary and outlook
Until recently, interventional research proving that nutri-
tional support improves clinical outcomes has been lack-
ing. There have been several publications on the beneficial
aspects of nutritional interventions, which showed im-
provement of nutritional parameters and quality of life, but
did not evaluate the influence on overall survival [47]. Re-
cent high-quality trials such as the NOURISH and the EF-
FORT trials have provided important new evidence link-
ing nutritional support to better clinical outcomes in terms
of reduction of mortality and severe complications, as well
as functional outcomes and quality of life [48–50]. The re-
sults strongly support the systematic screening for malnu-
trition of medical inpatients followed by nutritional assess-
ment and initiation of individualised nutritional support in
patients at risk. These recommendations are also support-
ed by a recent systematic review and meta-analysis demon-
strating a 25% reduction in mortality and hospital readmis-
sion in patients receiving nutritional support [51]. It is now
time to consider nutrition as a medical treatment to com-
plement organ and disease-specific therapies.
Algorithm-guided clinical decision making for nutritional
support is the backbone of an evidence-based nutritional
strategy. It facilitates the management of individual pa-
tients on the ward, enables consistency of nutritional
strategies within a clinic and improves harmonisation of
nutritional strategies between clinics. This will potentially
lead to enhanced comparability and better conditions for
further research, which is urgently needed in order to max-
imise efficacy, minimise side effects and reduce the cost of
nutritional support.
In-hospital management of nutritional therapy may also be
combined with low-intensity resistance training to stimu-
late lean muscle growth. A meta-analysis of studies on pro-
gressive resistance training in older adults showed clear
benefits and improved physical function [7, 52–54]. Study
results showed that resistance exercise designed to reverse
muscle loss and low muscle protein synthesis was as effec-
tive in older adults as it was in younger individuals [55].
The temporal correlation of protein ingestion relative to
exercise may also support muscle mass regeneration. In a
study of younger adult men, the benefits of resistance exer-
cise on protein synthesis persisted up to 24 hours post-ex-
ercise and it should be considered, particularly in the out-
patient setting [56]. More research is needed to delineate
mechanisms which link physical activity and nutrition to
recovery of lost muscle protein in older adults.
As recovery of lost lean body mass is more difficult and
time-consuming than its preservation, early interventions
aimed at prevention are important. In patients already ex-
periencing significant muscle loss, nutritional therapy (as
well as guided exercise during hospitalisation) might not
be enough to rebuild muscle mass. Subsequent out-patient
programmes to optimise nutritional status and encourage
lean body mass gain could become part of the comprehen-
sive management of malnourished patients in the near fu-
ture. There are several small outpatient studies that demon-
strated the benefit of βHMB on the build-up of lean muscle
mass [57, 58]. These results, however, must be confirmed
by larger trials before they can be accepted as general rec-
ommendations.
Finally, further personalisation of the above-mentioned
general nutritional strategy will be necessary to maximise
the effect of nutritional interventions and exercise. The
term “personalised” highlights the fact that not all patients
respond in the same way to medical interventions. Whether
or not a patient benefits at any given point in time from nu-
tritional therapy and exercise may be affected by illness-
specific (e.g., comorbidities, inflammation, oxidative
stress) or patient-specific factors (e.g., age, sex, genetic
predisposition). The field of metabolomic research pre-
sents a promising new approach to personalise interven-
tions based on metabolic clusters and specific patient phe-
notypes.
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